JMS Co.,Ltd.

7702.T
Medical Instruments & Supplies
2026/11/06 19:48 Updated
Market Cap: $65.9M (¥10.4B)
Stock Price: $2.69 (¥426)
Exchange Rate: 1 USD = ¥158.48

Overview of Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 2027

Net sales were 32,391 million yen, up 0.5% year-over-year. Operating income was 9 million yen, ordinary loss was -145 million yen, and net loss attributable to owners of parent was -262 million yen. By region there were fluctuations in Japan, North America, China, Singapore, etc., with higher raw material costs and increased personnel expenses impacting results. Full-year forecasts were revised: net sales raised from 66,000 → 68,000 million yen, operating income revised to 1,000 million yen, while net income remains uncertain.

Importance:
Page Updated: November 7, 2026
IR Disclosure Date: November 6, 2026

Key Figures

  • Net Sales: 32,391 million yen (vs prior period +175 million yen)
  • Operating Income: 9 million yen (vs prior period +28 million yen)
  • Ordinary Income: -145 million yen
  • Quarterly Net Loss Attributable to Owners of Parent: -262 million yen
  • Full-year Net Sales Forecast: 68,000 million yen (vs previous +2,000 million yen)

AI要約

Summary of Performance

As an overview of consolidated financial results, net sales totaled 32,391 million yen (YoY +0.5%). Operating income was 9 million yen (YoY +28 million yen), progressing toward profitability, while ordinary income was a -145 million yen loss and quarterly net loss attributable to owners of parent was -262 million yen. By segment, increases and decreases were observed across Japan, North America, China, Singapore, Germany and others. Rising raw material costs and increased personnel expenses drove up expenses.

Outlook and Key Measures

Earnings forecasts have been revised. Full-year net sales are raised from prior forecast of 66,000 million yen to 68,000 million yen, and operating income is expected to be revised upward from prior 700 million yen to 1,000 million yen. Under assumptions including foreign exchange effects, persistently high raw material prices and cost increases will impact results, and measures including cost reductions and price pass-through will be implemented.

Segment Revenue by Region

Margin Analysis

Forecast vs Actual Comparison

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

JMS Co.,Ltd.

Company overview · Stock price · Financial data · All IR

View company page →